Global Pseudorabies Virus Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Pseudorabies Virus Vaccine Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Inactivated Vaccine
  • 1.2.2 Naturally Deficient Attenuated Vaccine
  • 1.2.3 Genetic Engineering Vaccine
• 1.3 Market Analysis by Applications
  • 1.3.1 Government Tender
  • 1.3.2 Market Sales
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2014-2024)
    • 1.4.1.2 Canada Market States and Outlook (2014-2024)
    • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2014-2024)
    • 1.4.2.2 France Market States and Outlook (2014-2024)
    • 1.4.2.3 UK Market States and Outlook (2014-2024)
    • 1.4.2.4 Russia Market States and Outlook (2014-2024)
    • 1.4.2.5 Italy Market States and Outlook (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2014-2024)
    • 1.4.3.2 Japan Market States and Outlook (2014-2024)
    • 1.4.3.3 Korea Market States and Outlook (2014-2024)
    • 1.4.3.4 India Market States and Outlook (2014-2024)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
    • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
    • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Merck
  • 2.1.1 Business Overview
  • 2.1.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Merck Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 China Biotechnology Co., Ltd.
  • 2.2.1 Business Overview
  • 2.2.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Zoetis
  • 2.3.1 Business Overview
  • 2.3.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Zoetis Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Merial Limited
  • 2.4.1 Business Overview
  • 2.4.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Merial Limited Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Wuhan Keqian Biological Co., Ltd.
  • 2.5.1 Business Overview
  • 2.5.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Boehringer Ingelheim Animal Health (USA) Co., Ltd.
  • 2.6.1 Business Overview
  • 2.6.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Sichuan Huashen
  • 2.7.1 Business Overview
  • 2.7.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Sichuan Huashen Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Anhui Divinity Biological Products
  • 2.8.1 Business Overview
  • 2.8.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Hipra
  • 2.9.1 Business Overview
  • 2.9.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Hipra Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 CHINA ANIMAL HUSBANDRY INDUSTRY
  • 2.10.1 Business Overview
  • 2.10.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Preh Bio
  • 2.11.1 Business Overview
  • 2.11.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Preh Bio Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Jilin Zhengye Bioengineering Group
  • 2.12.1 Business Overview
  • 2.12.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Haley
  • 2.13.1 Business Overview
  • 2.13.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Haley Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Huapai Biological Engineering Group Co., Ltd.
  • 2.14.1 Business Overview
  • 2.14.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Jiangsu Nannong High-Tech Co.
  • 2.15.1 Business Overview
  • 2.15.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Harvey
  • 2.16.1 Business Overview
  • 2.16.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Harvey Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Tianbang
  • 2.17.1 Business Overview
  • 2.17.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Tianbang Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Jilin Heyuan Biological Engineering Co., Ltd.
  • 2.18.1 Business Overview
  • 2.18.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 Guangxi Liyuan Biological Co., Ltd.
  • 2.19.1 Business Overview
  • 2.19.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 Dabei Nong
  • 2.20.1 Business Overview
  • 2.20.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 Dabei Nong Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.21 Liaoning Yikang Biological Co., Ltd.
  • 2.21.1 Business Overview
  • 2.21.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.21.2.1 Product A
    • 2.21.2.2 Product B
  • 2.21.3 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.22 Beijing Xinde Weite Technology Co., Ltd.
  • 2.22.1 Business Overview
  • 2.22.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.22.2.1 Product A
    • 2.22.2.2 Product B
  • 2.22.3 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.23 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.
  • 2.23.1 Business Overview
  • 2.23.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.23.2.1 Product A
    • 2.23.2.2 Product B
  • 2.23.3 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.24 Yunnan Biopharmaceutical Co.
  • 2.24.1 Business Overview
  • 2.24.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.24.2.1 Product A
    • 2.24.2.2 Product B
  • 2.24.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.25 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.
  • 2.25.1 Business Overview
  • 2.25.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.25.2.1 Product A
    • 2.25.2.2 Product B
  • 2.25.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.26 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.
  • 2.26.1 Business Overview
  • 2.26.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.26.2.1 Product A
    • 2.26.2.2 Product B
  • 2.26.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.27 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
  • 2.27.1 Business Overview
  • 2.27.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.27.2.1 Product A
    • 2.27.2.2 Product B
  • 2.27.3 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.28 Beijing Veterinary Biopharmaceutical Factory
  • 2.28.1 Business Overview
  • 2.28.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.28.2.1 Product A
    • 2.28.2.2 Product B
  • 2.28.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.29 Shanghui Huahong Biological Engineering Co., Ltd.
  • 2.29.1 Business Overview
  • 2.29.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.29.2.1 Product A
    • 2.29.2.2 Product B
  • 2.29.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.30 Qilu Animal Health Products Co., Ltd.
  • 2.30.1 Business Overview
  • 2.30.2 Pseudorabies Virus Vaccine Type and Applications
    • 2.30.2.1 Product A
    • 2.30.2.2 Product B
  • 2.30.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Pseudorabies Virus Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

• 3.1 Global Pseudorabies Virus Vaccine Sales and Market Share by Manufacturer (2017-2018)
• 3.2 Global Pseudorabies Virus Vaccine Revenue and Market Share by Manufacturer (2017-2018)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Pseudorabies Virus Vaccine Manufacturer Market Share in 2018
  • 3.3.2 Top 6 Pseudorabies Virus Vaccine Manufacturer Market Share in 2018
• 3.4 Market Competition Trend

4 Global Pseudorabies Virus Vaccine Market Analysis by Regions

• 4.1 Global Pseudorabies Virus Vaccine Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Pseudorabies Virus Vaccine Sales and Market Share by Regions (2014-2019)
  • 4.1.2 Global Pseudorabies Virus Vaccine Revenue and Market Share by Regions (2014-2019)
• 4.2 North America Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 4.3 Europe Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 4.5 South America Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)

5 North America Pseudorabies Virus Vaccine by Country

• 5.1 North America Pseudorabies Virus Vaccine Sales, Revenue and Market Share by Country
  • 5.1.1 North America Pseudorabies Virus Vaccine Sales and Market Share by Country (2014-2019)
  • 5.1.2 North America Pseudorabies Virus Vaccine Revenue and Market Share by Country (2014-2019)
• 5.2 United States Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 5.3 Canada Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 5.4 Mexico Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)

6 Europe Pseudorabies Virus Vaccine by Country

• 6.1 Europe Pseudorabies Virus Vaccine Sales, Revenue and Market Share by Country
  • 6.1.1 Europe Pseudorabies Virus Vaccine Sales and Market Share by Country (2014-2019)
  • 6.1.2 Europe Pseudorabies Virus Vaccine Revenue and Market Share by Country (2014-2019)
• 6.2 Germany Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 6.3 UK Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 6.4 France Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 6.5 Russia Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 6.6 Italy Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)

7 Asia-Pacific Pseudorabies Virus Vaccine by Country

• 7.1 Asia-Pacific Pseudorabies Virus Vaccine Sales, Revenue and Market Share by Country
  • 7.1.1 Asia-Pacific Pseudorabies Virus Vaccine Sales and Market Share by Country (2014-2019)
  • 7.1.2 Asia-Pacific Pseudorabies Virus Vaccine Revenue and Market Share by Country (2014-2019)
• 7.2 China Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 7.3 Japan Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 7.4 Korea Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 7.5 India Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 7.6 Southeast Asia Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)

8 South America Pseudorabies Virus Vaccine by Country

• 8.1 South America Pseudorabies Virus Vaccine Sales, Revenue and Market Share by Country
  • 8.1.1 South America Pseudorabies Virus Vaccine Sales and Market Share by Country (2014-2019)
  • 8.1.2 South America Pseudorabies Virus Vaccine Revenue and Market Share by Country (2014-2019)
• 8.2 Brazil Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 8.3 Argentina Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 8.4 Colombia Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)

9 Middle East and Africa Pseudorabies Virus Vaccine by Countries

• 9.1 Middle East and Africa Pseudorabies Virus Vaccine Sales, Revenue and Market Share by Country
  • 9.1.1 Middle East and Africa Pseudorabies Virus Vaccine Sales and Market Share by Country (2014-2019)
  • 9.1.2 Middle East and Africa Pseudorabies Virus Vaccine Revenue and Market Share by Country (2014-2019)
• 9.2 Saudi Arabia Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 9.3 Turkey Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 9.4 Egypt Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 9.5 Nigeria Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)
• 9.6 South Africa Pseudorabies Virus Vaccine Sales and Growth Rate (2014-2019)

10 Global Pseudorabies Virus Vaccine Market Segment by Type

• 10.1 Global Pseudorabies Virus Vaccine Sales, Revenue and Market Share by Type (2014-2019)
  • 10.1.1 Global Pseudorabies Virus Vaccine Sales and Market Share by Type (2014-2019)
  • 10.1.2 Global Pseudorabies Virus Vaccine Revenue and Market Share by Type (2014-2019)
• 10.2 Inactivated Vaccine Sales Growth and Price
  • 10.2.1 Global Inactivated Vaccine Sales Growth (2014-2019)
  • 10.2.2 Global Inactivated Vaccine Price (2014-2019)
• 10.3 Naturally Deficient Attenuated Vaccine Sales Growth and Price
  • 10.3.1 Global Naturally Deficient Attenuated Vaccine Sales Growth (2014-2019)
  • 10.3.2 Global Naturally Deficient Attenuated Vaccine Price (2014-2019)
• 10.4 Genetic Engineering Vaccine Sales Growth and Price
  • 10.4.1 Global Genetic Engineering Vaccine Sales Growth (2014-2019)
  • 10.4.2 Global Genetic Engineering Vaccine Price (2014-2019)

11 Global Pseudorabies Virus Vaccine Market Segment by Application

• 11.1 Global Pseudorabies Virus Vaccine Sales Market Share by Application (2014-2019)
• 11.2 Government Tender Sales Growth (2014-2019)
• 11.3 Market Sales Sales Growth (2014-2019)

12 Pseudorabies Virus Vaccine Market Forecast (2019-2024)

• 12.1 Global Pseudorabies Virus Vaccine Sales, Revenue and Growth Rate (2019-2024)
• 12.2 Pseudorabies Virus Vaccine Market Forecast by Regions (2019-2024)
  • 12.2.1 North America Pseudorabies Virus Vaccine Market Forecast (2019-2024)
  • 12.2.2 Europe Pseudorabies Virus Vaccine Market Forecast (2019-2024)
  • 12.2.3 Asia-Pacific Pseudorabies Virus Vaccine Market Forecast (2019-2024)
  • 12.2.4 South America Pseudorabies Virus Vaccine Market Forecast (2019-2024)
  • 12.2.5 Middle East and Africa Pseudorabies Virus Vaccine Market Forecast (2019-2024)
• 12.3 Pseudorabies Virus Vaccine Market Forecast by Type (2019-2024)
  • 12.3.1 Global Pseudorabies Virus Vaccine Sales Forecast by Type (2019-2024)
  • 12.3.2 Global Pseudorabies Virus Vaccine Market Share Forecast by Type (2019-2024)
• 12.4 Pseudorabies Virus Vaccine Market Forecast by Application (2019-2024)
  • 12.4.1 Global Pseudorabies Virus Vaccine Sales Forecast by Application (2019-2024)
  • 12.4.2 Global Pseudorabies Virus Vaccine Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology